Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®

BACKGROUND: Safety and efficacy of the combined monthly use of spot-on fipronil 6.76% w/v / permethrin 50.48% w/v (Frontline Tri-Act®) and chewable tablets of afoxolaner 1.9% w/w / milbemycin oxime 0.4% w/w (NexGard Spectra®) in dogs was evaluated in a field study over a period of 6 months. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbate, Jessica M., Napoli, Ettore, Arfuso, Francesca, Gaglio, Gabriella, Giannetto, Salvatore, Halos, Lenaig, Beugnet, Frederic, Brianti, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048810/
https://www.ncbi.nlm.nih.gov/pubmed/30012179
http://dx.doi.org/10.1186/s13071-018-2957-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048810/
https://www.ncbi.nlm.nih.gov/pubmed/30012179
http://dx.doi.org/10.1186/s13071-018-2957-7

Ejemplares similares